Leqembi is not a cure for Alzheimers, and it wont restore memories.
Heres why it wont be accessibleor appropriatefor everyone with mild Alzheimers.
Private insurers are also expected to cover Leqembi for eligible patients.
Photo Illustration by Amelia Manley for Verywell Health; Getty Images
A copay will still be necessary in many cases.
Side Effects
The most significant side effects reported during the Leqembi trial were brain bleeding and brain swelling.
Potential Contraindications
Taking blood thinners such as Warfarin or Xarelto puts patients at higher risk of brain bleeding.
The FDA hasnt disqualified people on those drugs from taking Leqembi, but it does note the concern.
Other clinics may take time to ramp up.
Eisai.FDA grants traditional approval for Leqembi (lecanemab-irmb) for the treatment of Alzheimers disease.
